NSE · AMBALALSA
Ambalal Sarabhai Enterprises Limited
Historical price visualisation is temporarily undergoing corporate data-licensing maintenance. Full interactive price and chart data will return following our upcoming authorized NSE/BSE data-feed deployment. Derived metrics (valuation ratios, market-cap rank), company financials, shareholding, corporate actions, and mutual-fund holdings remain available.
Market cap rank
#2,179
of 5,072 stocks
▲ 221W
Peak #2,179 · 27 Sep 2026
Ambalal Sarabhai Enterprises Limited, a microcap Healthcare business, is growing revenue modestly, trades at a moderate earnings multiple, and posts a modest return on equity.
Market Cap
314.89 Cr
P/E Ratio
17.71
P/B Ratio
1.99
ROE
11.24%
ROCE
12.59%
Dividend Yield
—
52W High
—
52W Low
—
Quarterly financials
| Metric | Q1 2026-27 | Q4 2025-26 | Q3 2025-26 | Q2 2025-26 |
|---|---|---|---|---|
| Revenue | 43.56 Cr | 65.49 Cr | 52.00 Cr | 44.45 Cr |
| Net Profit | 3.98 Cr | 6.50 Cr | 3.64 Cr | -56.03 L |
| EPS | 0.52 | 0.85 | 0.40 | 0.07 |
| Operating Profit | 5.22 Cr | 7.26 Cr | 5.70 Cr | 1.08 Cr |
Shareholding pattern
Promoter
31.36%
Public
68.64%
Mutual fund holdings
Mutual fund holdings data for this stock hasn't been ingested yet — check back soon.
Recent corporate actions
No corporate actions on record for this stock.
Need this data in your app?
Full price history, technical indicators, and every field above via one REST API call.